p53 expression in node-positive breast cancer patients: Results from the cancer and leukemia group B 9344 trial (159905).
Clinical Cancer Research.
Times cited: 24
HER2 and response to paclitaxel in node-positive breast cancer.
New England Journal of Medicine.
Times cited: 478
Comparison of HER2 status by fluorescence in situ hybridization and immunohistochemistry to predict benefit from dose escalation of adjuvant doxorubicin-based therapy in node-positive breast cancer patients.
Journal of Clinical Oncology.
Times cited: 95